Laboratorio Reig Jofre (XMAD:RJF) 3-Year EBITDA Growth Rate : 11.70% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre 3-Year EBITDA Growth Rate?

Laboratorio Reig Jofre's EBITDA per Share for the three months ended in Dec. 2023 was €0.10.

During the past 12 months, Laboratorio Reig Jofre's average EBITDA Per Share Growth Rate was 12.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Laboratorio Reig Jofre was 146.00% per year. The lowest was -57.30% per year. And the median was 9.60% per year.

Competitive Comparison of Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate falls into.

Laboratorio Reig Jofre 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Laboratorio Reig Jofre (XMAD:RJF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Laboratorio Reig Jofre 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

FEQ1:Germany

Address

Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970

Website

http://www.reigjofre.com

Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.